全文获取类型
收费全文 | 2798篇 |
免费 | 295篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 142篇 |
妇产科学 | 99篇 |
基础医学 | 364篇 |
口腔科学 | 37篇 |
临床医学 | 234篇 |
内科学 | 624篇 |
皮肤病学 | 85篇 |
神经病学 | 176篇 |
特种医学 | 76篇 |
外科学 | 414篇 |
综合类 | 84篇 |
一般理论 | 1篇 |
预防医学 | 294篇 |
眼科学 | 59篇 |
药学 | 224篇 |
肿瘤学 | 160篇 |
出版年
2022年 | 13篇 |
2021年 | 44篇 |
2020年 | 28篇 |
2019年 | 33篇 |
2018年 | 52篇 |
2017年 | 32篇 |
2016年 | 41篇 |
2015年 | 42篇 |
2014年 | 72篇 |
2013年 | 79篇 |
2012年 | 144篇 |
2011年 | 151篇 |
2010年 | 61篇 |
2009年 | 55篇 |
2008年 | 124篇 |
2007年 | 132篇 |
2006年 | 127篇 |
2005年 | 112篇 |
2004年 | 115篇 |
2003年 | 147篇 |
2002年 | 147篇 |
2001年 | 99篇 |
2000年 | 103篇 |
1999年 | 91篇 |
1998年 | 41篇 |
1997年 | 28篇 |
1996年 | 37篇 |
1995年 | 31篇 |
1994年 | 37篇 |
1993年 | 32篇 |
1992年 | 65篇 |
1991年 | 66篇 |
1990年 | 52篇 |
1989年 | 51篇 |
1988年 | 54篇 |
1987年 | 42篇 |
1986年 | 49篇 |
1985年 | 55篇 |
1984年 | 43篇 |
1983年 | 30篇 |
1982年 | 32篇 |
1981年 | 16篇 |
1980年 | 22篇 |
1979年 | 45篇 |
1978年 | 28篇 |
1977年 | 24篇 |
1975年 | 24篇 |
1974年 | 17篇 |
1973年 | 21篇 |
1972年 | 13篇 |
排序方式: 共有3111条查询结果,搜索用时 234 毫秒
1.
2.
Emmi Helle Aldo Córdova-Palomera Tiina Ojala Priyanka Saha Praneetha Potiny Stefan Gustafsson Erik Ingelsson Michael Bamshad Deborah Nickerson Jessica X. Chong University of Washington Center for Mendelian Genomics Euan Ashley James R. Priest 《Genetic epidemiology》2019,43(2):215-226
Loss of function variants in NOTCH1 cause left ventricular outflow tract obstructive defects (LVOTO). However, the risk conferred by rare and noncoding variants in NOTCH1 for LVOTO remains largely uncharacterized. In a cohort of 49 families affected by hypoplastic left heart syndrome, a severe form of LVOTO, we discovered predicted loss of function NOTCH1 variants in 6% of individuals. Rare or low-frequency missense variants were found in 16% of families. To make a quantitative estimate of the genetic risk posed by variants in NOTCH1 for LVOTO, we studied associations of 400 coding and noncoding variants in NOTCH1 in 1,085 cases and 332,788 controls from the UK Biobank. Two rare intronic variants in strong linkage disequilibrium displayed significant association with risk for LVOTO amongst European-ancestry individuals. This result was replicated in an independent analysis of 210 cases and 68,762 controls of non-European and mixed ancestry. In conclusion, carrying rare predicted loss of function variants in NOTCH1 confer significant risk for LVOTO. In addition, the two intronic variants seem to be associated with an increased risk for these defects. Our approach demonstrates the utility of population-based data sets in quantifying the specific risk of individual variants for disease-related phenotypes. 相似文献
3.
4.
AIM: To assess the efficacy of intravesical botulinum toxin type A (BTX-A) in interstitial cystitis (IC). METHODS: Eleven patients with IC were injected with BTX-A. Primary outcome measures were: Bristol Female Lower Urinary Tract Symptom Score, Kings Health Questionnaire and 24-hour frequency-volume chart. They had urodynamics done before and six weeks after injection. Detrusor contractility was assessed using the modified PIP1 (projected isovolumetric detrusor pressure). 相似文献
5.
An in-vitro study of the interactions between intravenous induction agents and the calcium antagonists verapamil and nifedipine 总被引:1,自引:0,他引:1
Thiopentone, propofol and etomidate inhibit the contractions of the rat isolated atria and portal vein. The actions of thiopentone and propofol summate with those of verapamil and nifedipine. Verapamil potentiates the action of etomidate on both preparations. The depressant actions of thiopentone and propofol on the portal vein are associated with a reduced response to calcium. Etomidate does not reduce the response to calcium in this preparation. 相似文献
6.
7.
A H Filipovich D Vallera P McGlave D Polich K Gajl-Peczalska R Haake L Lasky B Blazar N K Ramsay J Kersey 《Transplantation》1990,50(3):410-415
Twenty-nine patients with advanced leukemias (median age 34 years) received histocompatible sibling marrow that had been depleted of T cells by ex vivo incubation with anti-CD5 monoclonal antibody-ricin immunotoxin (T101-R) for the purpose of graft-versus-host disease prophylaxis. Donor cell engraftment was documented in 28/29 patients by DNA restriction fragment length polymorphisms. In this pilot study the dose of T101-R incubated with donor marrow was increased in a stepwise manner from 300 ng (10 patients) to 600 ng (5 patients) to 1000 ng immunotoxin (IT)/10(7) bone marrow mononuclear cells (14 patients) in an attempt to achieve more effective GvHD prophylaxis. A statistically significant reduction in acute GvHD was achieved for patients receiving marrow pretreated with 1000 ng of immunotoxin (34%) compared to recipients of BM treated with 300 ng immunotoxin (100%, P = 0.0004). T-depleted marrow samples were evaluated for residual T cell activity using several in vitro assays including proliferation to the purified mitogen PHA (HA-17) and in mixed lymphocyte culture (MLC), T cell cytotoxicity, a limiting dilution assay for detecting precursors of proliferating T cells (LDApPTL), and phenotypic analysis of viable T cells expanded in 16-day culture with interleukin 2. The extent of T cell depletion determined by LDA assay varied widely at each immunotoxin concentration used. Thus, there was no correlation between the dose of T cells infused and subsequent GvHD. Phenotyping of lymphocytes recovered from immunotoxin-treated marrow demonstrated that residual T cells were CD5 negative in all cases tested. The only in vitro parameter that predicted subsequent acute or chronic GvHD was the demonstration of viable CD5 negative lymphocytes with T cell phenotype (CD2, CD3, and/or CD7 positive) after 16-day culture with IL-2 of the T-depleted bone marrow. We observed that such CD5 negative cells expressing other T cell markers have cytotoxic function and speculate that these cells may be capable of mediating GvHD in allogeneic transplantation. 相似文献
8.
9.
Laser Treatment of Endobronchial Lesions 总被引:2,自引:0,他引:2
10.